News & Analysis on Clinical Trial Services & Contract Research And Development
Profile Therapeutics of the UK, a specialist in inhaled therapies, said it has agreed to supply France's Schering SA with its Prodose intelligent inhalers to support Schering's product Ventavis (iloprost), a recently-approved medicine for primary...
A recently-formed UK company has developed a simple solution to avoiding one of the most fundamental problems affecting pharmaceutical products: contamination with water.
The first draft sequence of the genome of the chimpanzee has been completed, providing a tantalising first glimpse of the genetic differences that separates man from one of its closest cousins in the animal kingdom.
The amount of pharmaceutical R&D funding headed out-of-house to research suppliers engaged in drug development work will grow almost 15 per cent annually for the next five years, nearly double the anticipated increase in overall R&D spending,...
The lacklustre growth in the chemicals industry will continue to lag behind world gross domestic product (GDP) growth over the next few years, a reversal of the situation before 2000, according to BASF chairman Juergen Hambrecht.
Scotland's PPL Therapeutics, once one of the brightest stars in the UK biotechnology universe, came to desultory end this week when the company auctioned off most of its remaining assets for just £169,000 (€242,000).